The foundation committed $755,000 to a grant titled “Alzheimer’s Disease Biomarkers and Risk Disclosure” to identify biomarkers and undertake cognitive assessments for early detection to evaluate informed treatment decisions and early detection through biomarker development, PET and retinal imaging biomarkers, and the development of a machine-learning based individual AD Risk Algorithm.
